Evidence map›Paper›PMID 37176622›Full record

ArticleJournal of clinical medicine2023

A 2-Year Audit on Antibiotic Resistance Patterns from a Urology Department in Greece.

Ioannis Manolitsis, Georgios Feretzakis, Stamatios Katsimperis, Panagiotis Angelopoulos, Evangelos Loupelis, Nikoleta Skarmoutsou, Lazaros Tzelves, Andreas Skolarikos

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ioannis ManolitsisSecond Department of Urology, Sismanogleio General Hospital, 15126 Marousi, Greece.ORCID 0000-0003-1496-0742
Georgios FeretzakisSchool of Science and Technology, Hellenic Open University, 26335 Patras, Greece.ORCID 0000-0002-3597-1187
Stamatios KatsimperisSecond Department of Urology, Sismanogleio General Hospital, 15126 Marousi, Greece.ORCID 0000-0002-7028-1544
Panagiotis AngelopoulosSecond Department of Urology, Sismanogleio General Hospital, 15126 Marousi, Greece.
Evangelos LoupelisIT Department, Sismanogleio General Hospital, 15126 Marousi, Greece.
Nikoleta SkarmoutsouMicrobiology Laboratory, Sismanogleio General Hospital, 15126 Marousi, Greece.
Lazaros TzelvesSecond Department of Urology, Sismanogleio General Hospital, 15126 Marousi, Greece.ORCID 0000-0003-4619-9783
Andreas SkolarikosSecond Department of Urology, Sismanogleio General Hospital, 15126 Marousi, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe high incidence of urinary tract infections (UTIs), often in nosocomial environments, is a major cause of antimicrobial resistance (AMR). The dissemination of antibiotic-resistant infections results in very high health and economic burdens for patients and healthcare systems, respectively. This study aims to determine and present the antibiotic resistance profiles of the most common pathogens in a urology department in Greece.

methodsDuring the period 2019-2020, we included 12,215 clinical samples of blood and urine specimens that tested positive for the following pathogens:

resultsThe analysis revealed a 22.30% mean resistance rate of

conclusionsThe dissemination of antibiotic-resistant pathogens poses the need to implement surveillance programs and, consequently, to develop strategies to prevent the emergence of such pathogens in order to optimize patient outcomes.

Indexed as

antibioticsantimicrobial resistancemultidrug resistanceurinary tract infectionsurological infections

Identifiers

PMID37176622
PMCPMC10178956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.